The Food and Drug Administration is allowing a manufacturer of self-defense knives to begin selling immunity defense knives after years of regulatory uncertainty, according to sources familiar with the matter.
The agency has permitted manufacturers to sell the products in limited markets, but has not set a firm deadline for the devices to become available.
The FDA is also poised to allow immunity defense products to be marketed to people who have been injured or killed by a crime, the sources said.
The device, known as the MCP-7, is similar to a self-defence knife, but the patented design allows it to be carried in an open holster.
The MCP 7 is not a self defense knife, however, and has been approved for use by the U.S. Army and the U,S.
The MCP is also approved for civilian use.
The FDA approved the MCH-P7 in 2013, according a spokesman.
The product was originally developed by a New York City company called CQD Arms.CQD is no longer in business, the spokesman said.
In February, the FDA granted immunity defense makers the right to sell self- defense knives in a limited market for five years, with the aim of helping people who are victims of domestic violence or stalking.
The new product is intended to help people who suffer from post traumatic stress disorder, a condition that can cause physical pain and depression.
A spokesperson for the FDA said the agency is considering expanding the product’s use to people with other medical conditions, including schizophrenia and PTSD.
“As with other products currently on the market, we have not set any specific timetable for the availability of this product,” the FDA spokesperson said in an email.
“This decision will be reviewed and approved in light of any changes in the market.”